These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9663690)

  • 1. Venoms, antivenoms and immunotherapy.
    Chippaux JP; Goyffon M
    Toxicon; 1998 Jun; 36(6):823-46. PubMed ID: 9663690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation.
    Gutiérrez JM; León G; Lomonte B
    Clin Pharmacokinet; 2003; 42(8):721-41. PubMed ID: 12846594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of 125I-labelled IgG, F(ab')2 and Fab fractions of scorpion and snake antivenins: merits and potential for therapeutic use.
    Ismail M; Abd-Elsalam MA
    Toxicon; 1998 Nov; 36(11):1523-8. PubMed ID: 9792168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development and use of immunotherapy in Africa.
    Chippaux JP
    Toxicon; 1998 Nov; 36(11):1503-6. PubMed ID: 9792164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-reagent one-step procedures for the purification of ovine IgG, F(ab')2 and Fab antivenoms by caprylic acid.
    Al-Abdulla I; Casewell NR; Landon J
    J Immunol Methods; 2014 Jan; 402(1-2):15-22. PubMed ID: 24246428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antivenoms for snakebite envenomings.
    Gutiérrez JM; León G; Lomonte B; Angulo Y
    Inflamm Allergy Drug Targets; 2011 Oct; 10(5):369-80. PubMed ID: 21745181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-human erythrocyte antibodies in horse-derived antivenoms used in the treatment of snakebite envenomations.
    León G; Rodríguez MA; Rucavado A; Lomonte B; Gutiérrez JM
    Biologicals; 2007 Mar; 35(1):5-11. PubMed ID: 16490363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Snake bites by European vipers in Mainland France in 2017-2018: comparison of two antivenoms Viperfav
    Boels D; Hamel JF; Le Roux G; Labadie M; Paret N; Delcourt N; Langrand J; Puskarczyk E; Nisse P; Sinno-Tellier S; de Haro L
    Clin Toxicol (Phila); 2020 Nov; 58(11):1050-1057. PubMed ID: 32134691
    [No Abstract]   [Full Text] [Related]  

  • 9. First clinical experiences with specific sheep Fab fragments in snake bite. Report of a multicentre study of Vipera berus envenoming.
    Karlson-Stiber C; Persson H; Heath A; Smith D; al-Abdulla IH; Sjöström L
    J Intern Med; 1997 Jan; 241(1):53-8. PubMed ID: 9042094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human heterophilic antibodies against equine immunoglobulins: assessment of their role in the early adverse reactions to antivenom administration.
    León G; Segura A; Herrera M; Otero R; França FO; Barbaro KC; Cardoso JL; Wen FH; de Medeiros CR; Prado JC; Malaque CM; Lomonte B; Gutiérrez JM
    Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1115-9. PubMed ID: 18561967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New techniques in antivenom production and active immunization against snake venoms.
    Theakston RD
    Trans R Soc Trop Med Hyg; 1989; 83(4):433-5. PubMed ID: 2694474
    [No Abstract]   [Full Text] [Related]  

  • 12. An objective approach to antivenom therapy and assessment of first-aid measures in snake bite.
    Theakston RD
    Ann Trop Med Parasitol; 1997 Oct; 91(7):857-65. PubMed ID: 9625943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First clinical experiences with a new ovine Fab Echis ocellatus snake bite antivenom in Nigeria: randomized comparative trial with Institute Pasteur Serum (Ipser) Africa antivenom.
    Meyer WP; Habib AG; Onayade AA; Yakubu A; Smith DC; Nasidi A; Daudu IJ; Warrell DA; Theakston RD
    Am J Trop Med Hyg; 1997 Mar; 56(3):291-300. PubMed ID: 9129531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population Pharmacokinetics of an Indian F(ab')2 Snake Antivenom in Patients with Russell's Viper (Daboia russelii) Bites.
    Isbister GK; Maduwage K; Saiao A; Buckley NA; Jayamanne SF; Seyed S; Mohamed F; Chathuranga U; Mendes A; Abeysinghe C; Karunathilake H; Gawarammana I; Lalloo DG; de Silva HJ
    PLoS Negl Trop Dis; 2015; 9(7):e0003873. PubMed ID: 26135318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study of tolerance and effectiveness of a F(ab')(2) polyvalent antienom for African snake bites in Kindia, Guinea].
    Baldé MC; Chippaux JP; Boiro MY; Stock R; Massougbodji A
    Bull Soc Pathol Exot; 2012 Aug; 105(3):157-61. PubMed ID: 22359185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of antivenoms in the treatment of snake envenomation].
    Chippaux JP
    Bull Acad Natl Med; 2013; 197(4-5):993-1006; discussion 1006-8. PubMed ID: 25518165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of the efficacy and safety of two polyvalent, caprylic acid fractionated [IgG and F(ab')2] antivenoms, in Bothrops asper bites in Colombia.
    Otero-Patiño R; Segura A; Herrera M; Angulo Y; León G; Gutiérrez JM; Barona J; Estrada S; Pereañez A; Quintana JC; Vargas LJ; Gómez JP; Díaz A; Suárez AM; Fernández J; Ramírez P; Fabra P; Perea M; Fernández D; Arroyo Y; Betancur D; Pupo L; Córdoba EA; Ramírez CE; Arrieta AB; Rivero A; Mosquera DC; Conrado NL; Ortiz R
    Toxicon; 2012 Feb; 59(2):344-55. PubMed ID: 22146491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study on the ability of IgG and F(ab')2 antivenoms to neutralize lethal and myotoxic effects induced by Micrurus nigrocinctus (coral snake) venom.
    León G; Stiles B; Alape A; Rojas G; Gutiérrez JM
    Am J Trop Med Hyg; 1999 Aug; 61(2):266-71. PubMed ID: 10463678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG subclass distributions of anti-horse serum antibodies and natural venom-antibodies produced in response to antivenom injection or snake bite in humans.
    Ameno S; Ameno K; Fuke C; Kiryu T; Ijiri I
    Toxicon; 1990; 28(3):347-50. PubMed ID: 2343468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Report of a WHO workshop on the standardization and control of antivenoms.
    Theakston RD; Warrell DA; Griffiths E
    Toxicon; 2003 Apr; 41(5):541-57. PubMed ID: 12676433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.